824 related articles for article (PubMed ID: 17979650)
1. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
2. Trends and developments in liposome drug delivery systems.
Lian T; Ho RJ
J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
[TBL] [Abstract][Full Text] [Related]
3. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
Immordino ML; Dosio F; Cattel L
Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
[TBL] [Abstract][Full Text] [Related]
4. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
Almeida B; Nag OK; Rogers KE; Delehanty JB
Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
[TBL] [Abstract][Full Text] [Related]
5. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
6. Challenges in development of targeted liposomal therapeutics.
Sawant RR; Torchilin VP
AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
[TBL] [Abstract][Full Text] [Related]
7. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
8. Design and simulation of the liposomal model by using a coarse-grained molecular dynamics approach towards drug delivery goals.
Parchekani J; Allahverdi A; Taghdir M; Naderi-Manesh H
Sci Rep; 2022 Feb; 12(1):2371. PubMed ID: 35149771
[TBL] [Abstract][Full Text] [Related]
9. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
10. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
[TBL] [Abstract][Full Text] [Related]
12. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
13. Future directions of liposome- and immunoliposome-based cancer therapeutics.
Park JW; Benz CC; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
[TBL] [Abstract][Full Text] [Related]
14. The potential of liposomes as dental drug delivery systems.
Nguyen S; Hiorth M; Rykke M; Smistad G
Eur J Pharm Biopharm; 2011 Jan; 77(1):75-83. PubMed ID: 20875853
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and disposition of various drug loaded liposomes.
Qian S; Li C; Zuo Z
Curr Drug Metab; 2012 May; 13(4):372-95. PubMed ID: 22443534
[TBL] [Abstract][Full Text] [Related]
16. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
Joguparthi V; Anderson BD
J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
[TBL] [Abstract][Full Text] [Related]
17. Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity.
Mukherjee B; Mondal L; Chakraborty S; Paul P; Choudhury A; Bhattacharya S; Hossain CM
Curr Pharm Biotechnol; 2015; 16(4):380-91. PubMed ID: 25658382
[TBL] [Abstract][Full Text] [Related]
18. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
Wang Y; Grainger DW
Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
[TBL] [Abstract][Full Text] [Related]
19. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
Giddam AK; Zaman M; Skwarczynski M; Toth I
Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
[TBL] [Abstract][Full Text] [Related]
20. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
